CC2: Reconciliation of regulatory capital to balance sheet
Sumitomo Mitsui Banking Corporation and Subsidiaries
a | |
Items | Consolidated balance |
sheet as in published | |
financial statements | |
(As of Mar. 31, 2021) | |
Assets | |
Cash and due from banks | 70,430,539 |
Call loans and bills bought | 3,253,463 |
Receivables under resale agreements | 4,827,826 |
Receivables under securities borrowing transactions | 1,602,444 |
Monetary claims bought | 4,657,587 |
Trading assets | 3,408,323 |
Money held in trust | 0 |
Securities | 35,493,879 |
Loans and bills discounted | 86,594,613 |
Foreign exchanges | 2,164,234 |
Lease receivables and investment assets | 236,392 |
Other assets | 5,063,312 |
Tangible fixed assets | 1,305,648 |
Intangible fixed assets | 346,534 |
Net defined benefit asset | 559,043 |
Deferred tax assets | 30,870 |
Customers' liabilities for acceptances and guarantees | 8,618,012 |
Reserve for possible loan losses | (526,161) |
Total assets | 228,066,567 |
Liabilities | |
Deposits | 142,486,668 |
Negotiable certificates of deposit | 12,760,617 |
Call money and bills sold | 536,515 |
Payables under repurchase agreements | 13,720,196 |
Payables under securities lending transactions | 551,377 |
Commercial paper | 1,686,404 |
Trading liabilities | 2,837,664 |
Borrowed money | 25,061,421 |
Foreign exchanges | 1,154,507 |
(Millions of yen) | |
b | c |
Reference to | Reference to |
Template | appended |
CC1 | table |
6-a
2-b,6-b
6-c
6-d
2-a
3
4-a
6-e
8-a
Bonds | 1,115,496 | 8-b |
Due to trust account | 2,321,223 | |
Other liabilities | 5,249,597 | 6-f |
Reserve for employee bonuses | 42,033 | |
Reserve for executive bonuses | 1,481 | |
Net defined benefit liability | 5,406 | |
Reserve for executive retirement benefits | 635 | |
Reserve for point service program | 603 | |
Reserve for reimbursement of deposits | 9,982 | |
Deferred tax liabilities | 620,747 | 4-b |
Deferred tax liabilities for land revaluation | 29,603 | 4-c |
Acceptances and guarantees | 8,618,012 | |
Total liabilities | 218,810,197 | |
Net assets | ||
Capital stock | 1,770,996 | 1-a |
Capital surplus | 1,966,300 | 1-b |
Retained earnings | 3,676,110 | 1-c |
Treasury stock | (210,003) | 1-d |
Total stockholders' equity | 7,203,404 | |
Net unrealized gains or losses on other securities | 1,748,263 | |
Net deferred gains or losses on hedges | 28,751 | 5 |
Land revaluation excess | 36,251 | |
Foreign currency translation adjustments | 12,494 | |
Accumulated remeasurements of defined benefit plans | 125,380 | |
Total accumulated other comprehensive income | 1,951,141 | (a) |
Non-controlling interests | 101,823 | 7-b |
Total net assets | 9,256,369 | |
Total liabilities and net assets | 228,066,567 |
Note: The regulatory scope of consolidation is the same as the accounting scope of consolidation.
(Appended Table)
1. Stockholders' equity | |||
(1) Consolidated balance sheet | (Millions of yen) | ||
Consolidated balance sheet items | As of Mar. 31, | Remarks | |
2021 | |||
Capital stock | 1,770,996 | Including eligible Tier 1 capital instruments subject to | |
transitional arrangement | |||
Capital surplus | 1,966,300 | Including eligible Tier 1 capital instruments subject to | |
transitional arrangement | |||
Retained earnings | 3,676,110 | ||
Treasury stock | (210,003) | Eligible Tier 1 capital instruments subject to transitional | |
arrangement | |||
Total stockholders' equity | 7,203,404 | ||
(2) Composition of capital | (Millions of yen) | ||
Composition of capital disclosure | As of Mar. 31, | Remarks | |
2021 | |||
Ref. No.
1-a
1-b
1-c
1-d
Basel III Template
No.
Directly issued qualifying common share capital plus related capital surplus and retained earnings
of which: capital and capital surplus
of which: retained earnings
of which: treasury stock (-)
of which: other than the above
Directly issued qualifying Additional Tier 1 instruments plus related capital surplus of which: classified as equity under applicable accounting standards and the breakdown
Stockholders' equity attributable to common shares (before
7,203,404 adjusting national specific regulatory adjustments (earnings to be distributed))
3,527,294
3,676,110
-
-
- Stockholders' equity attributable to preferred shares with a loss absorbency clause upon entering into effectively bankruptcy
1a
2
1c
31a
2. Intangible fixed assets
(1) Consolidated balance sheet
Consolidated balance sheet items
Intangible fixed assets Securities
of which: goodwill attributable to equity-method investees
Income taxes related to above
(2) Composition of capital
Composition of capital disclosure
Goodwill (including those equivalent)
Other intangibles other than goodwill and mortgage servicing rights
Mortgage servicing rights
Amount exceeding the 10% threshold on specified items
Amount exceeding the 15% threshold on specified items
Mortgage servicing rights that are below the thresholds for deduction (before risk weighting)
3. Net defined benefit asset
(1) Consolidated balance sheet
Consolidated balance sheet items
Net defined benefit asset
Income taxes related to above
(2) Composition of capital
Composition of capital disclosure
Net defined benefit asset
As of Mar. 31,
2021
346,534
35,493,879
7,837
101,703
As of Mar. 31,
2021
7,837
244,830 Software and other
-
-
-
-
As of Mar. 31,
2021
559,043
171,046
As of Mar. 31,
2021
387,997
(Millions of yen)
Remarks
(Millions of yen)
Remarks
(Millions of yen)
Remarks
(Millions of yen)
Remarks
Ref. No.
2-a
2-b
Basel III Template
No.
8
9
20
24
74
Ref. No.
3
Basel III Template
No.
15
4. Deferred tax assets
(1) Consolidated balance sheet
Consolidated balance sheet items
Deferred tax assets Deferred tax liabilities
Deferred tax liabilities for land revaluation
Tax effects on intangible fixed assets
Tax effects on net defined benefit asset
(2) Composition of capital
Composition of capital disclosure
(Millions of yen)
As of Mar. 31, | Remarks |
2021 | |
30,870 | |
620,747 | |
29,603 | |
101,703 | |
171,046 | |
(Millions of yen) | |
As of Mar. 31, | Remarks |
2021 | |
Ref. No.
4-a
4-b
4-c
Basel III Template
No.
Deferred tax assets that rely on future profitability excluding
those arising from temporary differences (net of related tax3,314 liability)
This item does not agree with the amount reported on the consolidated balance sheet due to offsetting of assets and liabilities.
10
Deferred tax assets arising from temporary differences (net of related tax liability)
Amount exceeding the 10% threshold on specified items
Amount exceeding the 15% threshold on specified items
Deferred tax assets arising from temporary differences that are below the thresholds for deduction (before risk weighting)
5. Deferred gains or losses on derivatives under hedge accounting
(1) Consolidated balance sheet
Consolidated balance sheet items
Net deferred gains or losses on hedges
3,945
-
-
3,945
As of Mar. 31,
2021
28,751
This item does not agree with the amount reported on the consolidated balance sheet due to offsetting of assets and liabilities.
(Millions of yen)
Remarks
21
25
75
Ref. No.
5
(2) Composition of capital | (Millions of yen) | ||
Composition of capital disclosure | As of Mar. 31, | Remarks | |
2021 | |||
Excluding those items whose valuation differences arising from | |||
Net deferred gains or losses on hedges | 32,799 hedged items are recognized as "Accumulated other | ||
comprehensive income" | |||
6. Items associated with investments in the capital of financial institutions | |||
(1) Consolidated balance sheet | (Millions of yen) | ||
Consolidated balance sheet items | As of Mar. 31, | Remarks | |
2021 | |||
Basel III Template
No.
11
Ref. No.
Trading assets | 3,408,323 |
Securities | 35,493,879 |
Loans and bills discounted | 86,594,613 |
Other assets | 5,063,312 |
Trading liabilities | 2,837,664 |
Other liabilities | 5,249,597 |
Including trading account securities and derivatives for trading assets
Including subordinated loans Including derivatives
Including trading account securities sold and derivatives for trading liabilities
Including derivatives
6-a
6-b
6-c
6-d
6-e
6-f
(2) Composition of capital | (Millions of yen) | |
Composition of capital disclosure | As of Mar. 31, | Remarks |
2021 | ||
Basel III Template
No.
Investments in own capital instruments | - |
Common Equity Tier 1 capital | - |
Additional Tier 1 capital | - |
Tier 2 capital | - |
Reciprocal cross-holdings in the capital of banking, financial | - |
and insurance entities | |
Common Equity Tier 1 capital | - |
Additional Tier 1 capital | - |
Tier 2 capital and other TLAC liabilities | - |
Investments in the capital of banking, financial and insurance | |
entities that are outside the scope of regulatory consolidation, | |
net of eligible short positions, where the bank does not own | 427,937 |
more than 10% of the issued share capital (amount above the | |
10% threshold) | |
Common Equity Tier 1 capital | - |
Additional Tier 1 capital | - |
Tier 2 capital and other TLAC liabilities | - |
Non-significant investments in the capital and other | |
TLAC liabilities of other financials that are below the | 427,937 |
thresholds for deductions (before risk weighting) | |
Significant investments in the capital of banking, financial and | |
insurance entities that are outside the scope of regulatory | 572,588 |
consolidation (net of eligible short positions) | |
Amount exceeding the 10% threshold on specified | - |
items | |
Amount exceeding the 15% threshold on specified | - |
items | |
Additional Tier 1 capital | 25,525 |
Tier 2 capital and other TLAC liabilities | 33,213 |
Significant investments in the common stock of other | |
financials that are below the thresholds for deductions | 513,849 |
(before risk weighting) | |
7. Non-controlling interests | |
(1) Consolidated balance sheet | |
Consolidated balance sheet items | As of Mar. 31, |
2021 | |
Non-controlling interests | 101,823 |
(2) Composition of capital | |
Composition of capital disclosure | As of Mar. 31, |
2021 | |
(Millions of yen)
Remarks
(Millions of yen)
Remarks
16
37
52
17
38
53
18
39
54
72
19
23
40
55
73
Ref. No.
7-b
Basel III Template
No.
Amount allowed in group CET1
Qualifying Additional Tier 1 instruments plus related capital surplus issued by special purpose vehicles and other equivalent entities
Amount allowed in group AT1
Qualifying Tier 2 instruments plus related capital surplus issued by special purpose vehicles and other equivalent entities
Amount allowed in group T2
1,145 After reflecting amounts eligible for inclusion (Non-Controlling Interest after adjustments)
- After reflecting amounts eligible for inclusion (Non-Controlling Interest after adjustments)
13,804 After reflecting amounts eligible for inclusion (Non-Controlling Interest after adjustments)
- After reflecting amounts eligible for inclusion (Non-Controlling Interest after adjustments)
2,395 After reflecting amounts eligible for inclusion (Non-Controlling Interest after adjustments)
5
30-31ab-32
34-35
46
48-49
8. Other capital instruments | |||
(1) Consolidated balance sheet | (Millions of yen) | ||
Consolidated balance sheet items | As of Mar. 31, | Remarks | |
2021 | |||
Borrowed money | 25,061,421 | ||
Bonds | 1,115,496 | ||
Total | 26,176,918 |
Ref. No.
8-a
8-b
(2) Composition of capital
Composition of capital disclosure
Directly issued qualifying Additional Tier 1 instruments plus related capital surplus of which: classified as liabilities under applicable accounting standards
Directly issued qualifying Tier 2 instruments plus related capital surplus of which: classified as liabilities under applicable accounting standards
(Millions of yen)
As of Mar. 31, | Remarks |
2021 | |
1,155,000 | |
863,542 |
Basel III Template
No.
32
46
Attachments
- Original document
- Permalink
Disclaimer
Sumitomo Mitsui Financial Group Inc. published this content on 29 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2021 09:32:12 UTC.